bioAffinity Technologies, Inc. (BIAF) Earnings Dates & History
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.89
-2.36%
Mkt Cap $19.92M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | $1.55M | $1.59M | +2.51% | -$2.70 | -$1.11 | +58.89% |
| Q4 2025 Nov 14, 2025 | $1.41M | $1.45M | +2.49% | -$2.70 | -$2.70 | +0.00% |
| Q3 2025 Aug 14, 2025 | $1.41M | $1.27M | -10.03% | -$2.70 | -$3.90 | -44.44% |
| Q2 2025 May 15, 2025 | $1.21M | $1.85M | +53.73% | -$0.16 | -$0.16 | +0.00% |
| Q1 2025 Mar 31, 2025 | $2.42M | $2.21M | -8.68% | -$0.14 | -$0.21 | -50.00% |
| Q4 2024 Nov 14, 2024 | $2.54M | $2.35M | -7.44% | -$0.15 | -$0.16 | -6.67% |
| Q3 2024 Aug 14, 2024 | $2.45M | $2.40M | -2.16% | -$0.17 | -$0.19 | -11.76% |
| Q2 2024 May 15, 2024 | $2.54M | $2.41M | -5.28% | -$0.15 | -$0.21 | -40.00% |
| Q2 2024 Apr 1, 2024 | $1.80M | $2.21M | +22.94% | -$0.20 | -$0.26 | -30.00% |
| Q4 2023 Nov 14, 2023 | $100.00K | $298.48K | +198.48% | -$0.18 | -$0.26 | -44.44% |
| Q3 2023 Aug 14, 2023 | — | $19.74K | — | -$0.13 | -$0.20 | -53.85% |
| Q2 2023 May 15, 2023 | $100.00K | $921 | -99.08% | -$0.21 | -$0.18 | +14.29% |
| Q1 2023 Mar 31, 2023 | — | $2.35K | — | -$0.19 | -$0.20 | -5.16% |
| Q4 2022 Nov 14, 2022 | — | $1.15K | — | — | -$1.10 | — |
| Q3 2022 Sep 2, 2022 | — | $1.31K | — | — | -$0.03 | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.54 | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$2.04 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.55 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | $0.54 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.26 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.80 | — |